RareStone Group is committed to establishing Greater China's first integrated rare disease ecosystem, transforming the lives of patients and families through world-class therapeutics and comprehensive, sustainable support services.
We have two subsidiaries under RareStone Group:
Citrine Medicine is a specialty pharmaceutical company dedicated to delivering innovative, accessible treatments for rare diseases in Greater China, with a focus on neurology. WAKIX® is our core product, which has been approved by China NMPA in 2023 for narcolepsy, and it has been listed in the National Reimbursement Drug List in 2023. WAKIX® has obtained pediatric narcolepsy indication from China NMPA in May 2024.
Zircon Health is a pioneering healthcare services platform building China's first rare disease ecosystem through:
- AI-powered, patient-centric disease management solutions
- Digital health technologies and big data analytics
- Comprehensive non-therapeutic support services
- Innovative payment models to enhance treatment accessibility
In July 2020, RareStone Group secured $80 million USD in Series A funding from leading investors including Eight Roads Ventures, F-Prime Capital, and Vivo Capital.
Company Details
- Employees
- 24
- Founded
- -
- Address
- 上海, Cn
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.rarestonegroup.com
- Keywords
- Rare disease ecosystem, Rare disease product platform, Wikipedia of rare disease, Biotechnology.
- HQ
- 上海
Rarestone Group Questions
Rarestone Group's website is http://www.rarestonegroup.com
Rarestone Group's LinkedIn profile is https://cn.linkedin.com/company/rarestone-group-%E7%90%85%E9%92%B0%E9%9B%86%E5%9B%A2
Rarestone Group has
24 employees.
View email and phone details for 24
employees at Rarestone Group.
Rarestone Group's industry is
Pharmaceutical Manufacturing
Rarestone Group's top competitors are
Geneditbio Limited,
Hengrui Pharma,
Vivo Capital,
Medis,
Visen Pharmaceuticals,
Duality Biologics,
Santen,
Specialised Therapeutics,
Tcgx,
Roche.
Rarestone Group's categories are Pharmaceutical Manufacturing
Rarestone Group's founding year is 2019
